FDA Information - November 20, 2008

Boston Scientific Recalls Enteryx Injection Kits

September 28, 2005 - Topics hospital, ulcer, fda, safety and food

Hector Duarte Jr. - All Headline News Staff Reporter

The company says some patients have been harmed because doctors used its Enteryx injection kit incorrectly

read more >>

FDA Endorses Expanded Use Of Lipitor

September 28, 2005 - Topics fda, disease, heart disease, blood and food
The Food and Drug Administration endorses expanding of the pool of people who use the popular cholesterol drug Lipitor
read more >>

Study Finds Paxil Possibly Linked To Birth Defects

September 28, 2005 - Topics study, paxil, women, pregnancy and studies
The Food and Drug Administration warns that a recent study suggests the antidepressant Paxil may be associated with birth defects.

Paxil's manufacturer, GlaxoSmithKline, says it will include the results of the study in the drug's precaution list

read more >>

ALS Moving Through FDA Approval

September 26, 2005 - Topics fda, pharmaceutical, food and disease
The U.S. Food and Drug Administration is fast tracking a new drug named "arimoclomol", for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

Pharmaceutical giant, CytRx, announces the initiation of a phase II clinical trial with orally-administered arimoclomol for ALS, and patient identification for this trial, which currently is underway at several clinical trial sites. Arimoclomol was granted orphan drug status designation by the FDA for the treatment of ALS in May 2005

read more >>

FDA Moving Ahead With ALS Drug

September 26, 2005 - Topics fda, pharmaceutical, food and disease
The U.S. Food and Drug Administration is fast tracking a new drug named "arimoclomol", for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

Pharmaceutical giant, CytRx, announces the initiation of a phase II clinical trial with orally-administered arimoclomol for ALS, and patient identification for this trial, which currently is underway at several clinical trial sites. Arimoclomol was granted orphan drug status designation by the FDA for the treatment of ALS in May 2005

read more >>





© Copyright 2008 Webmedia Publishing, SA - all rights reserved.     Contact Us  |  Privacy Policy  |  Disclaimer  |  Terms of Use